An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture

• Published in: Virology (New York, N.Y.) Vol. 422; no. 2; pp. 224 - 234
• Main Authors: Chan, Katie, Cheng, Guofeng, Beran, Rudolf K.F, Yang, Huiling, Appleby, Todd C, Pokrovskii, Maria V, Mo, Hongmei, Zhong, Weidong, Delaney, William E
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 20.01.2012
• Subjects: Adaptation, Physiological - genetics; Adaptive mutations; Cell culture; Cell culture adaptation; Cell Line; Chimera; Con1; Gene Expression Regulation, Viral - physiology; Genomes; Genotype; Genotypes; Hepacivirus - genetics; Hepacivirus - metabolism; Hepatitis C virus; Humans; Infectious Disease; Infectivity; JFH1; Models, Molecular; Mutation; Protein Conformation; Recombinant Proteins; Recombinants; Replication; Time Factors; Viral Nonstructural Proteins - genetics; Viral Nonstructural Proteins - metabolism; Viral Structural Proteins - genetics; Viral Structural Proteins - metabolism; Virus production; Cell culture adaptation; JFH1; Virus production; Adaptive mutations; Hepatitis C virus; Chimera; Con1
• ISSN: 0042-6822; 1096-0341
• DOI: 10.1016/j.virol.2011.10.022

Abstract The development of JFH1 based intergenotypic recombinants which exploit the unique replication characteristics of JFH1 has made it possible to study infectious HCV encoding the structural genes of additional HCV genotypes including genotype 1b. Although, intergenotypic 1b/2a chimeric genomes replicate efficiently in transfected cells they produce very low viral titers, limiting the utility of this system. Here, intergenotypic 1b/2a variants were generated by serially passaging the virus in a novel highly permissive Huh-7 cell clone. The adapted virus was 1000-fold more infectious than the parental unadapted virus and six adapted mutations were identified throughout the genome. Of the mutations identified, L839S in the NS2 gene was the most critical for the adapted phenotype by enhancing the infectivity of assembled viral particles. Overall, the efficient production of infectious 1b/2a virus particles will facilitate the discovery and characterization of inhibitors targeting steps that involve the structural genes of genotype 1b HCV.